Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in South Korea / NCT05776550
Active, not recruiting Observational

Safety and Efficacy of Distal Radial Access (SAFE-BOX)

NCT05776550 · tracked via the Priya Life Science South Korea tracker
Sponsor
Yonsei University
Phase
Observational
Started
2023-01-05
Last updated
2026-04-24

Condition(s) studied

SafetyEfficacy

Study summary

A Prospective Registry to assess the Safety and Efficacy of Distal Radial Approach

Eligibility

Sex
ALL
Min age
20 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: 1. Patients over 20 years of age 2. Patients requiring coronary angiography or intervention 3. Patients with palpable distant radial artery Exclusion Criteria: 1. Patients with distant radial artery too small or not palpable 2. Pregnant women 3. Patients not appropriate for the researcher to judge

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Yongcheol Kim Yongin Gyeonggi-do

More Yonsei University trials in South Korea

Effects of Cognitive Intervention Therapy on Postoperative Delirium Starting soon
Analgesic Efficacy of Maxigesic in Breast Cancer Surgery Recruiting
Appropriate Duration of Anti-Platelet straTegy in Patients With Advance Chronic Kidney Disease After New Generation Drug Eluting Stents (ADAPT-CKD) Recruiting
Artificial Intelligence Guided Patient Selection for Atrial Fibrillation Catheter Ablation: Randomized Clinical Trial (AI-PAFA Trial) Recruiting
Outcome in Patients Treated With Endovascular Thrombectomy - optIMAL Blood Pressure Control 2 (OPTIMAL-BP 2) Recruiting

Other trials for the same condition

A Study to Learn More About Prevenar 20 Once it is Out in the Korean Market Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05776550 on ClinicalTrials.gov ↗ ← All trials in South Korea